New: NCI-funded clinical trial search
Mednet Logo

What factors do you consider when electing to observe small brain metastases (vs treating with SRS)?

Community PollStarted

Would you hold off on SRS for a patient with metastatic NSCLC and multiple asymptomatic brain metastases who will be starting immunotherapy?

88 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Radiation Oncology · University of Colorado School of Medicine
Answered on

Since I see primarily brain metastases from lung cancer, my opinion will be confined to small cell and NSCLC brain metastases.

For single or multiple small (and I am going to assume that they are asymptomatic) that are present at the diagnosis of small cell lung cancer, I think it is reasonable to ...

Join for free or sign in to see the full answer